RGA 6450 — Financing and Reimbursement in Biomedical Product Development
2 semester hoursGraduateLecture
Introduces the complex discipline of global reimbursement and pricing strategy for medical devices, drugs, and biologic products. As cost and relative efficacy drivers become increasingly crucial to marketing biomedical products successfully, life-sciences regulatory professionals must evaluate regulatory compliance criteria concerning reimbursement and product pricing concerns. Regulatory professionals must also demonstrate that utilization of new biomedical products is comparatively cost-effective when measured against standards of clinical care. Using specific case studies from the United States and abroad, offers students an opportunity to analyze these market developments and their resulting implications for biomedical product development, manufacturing, and commercialization, with an overall objective to develop comparatively and financially informed regulatory systems.